At a glance
- Originator Nonindustrial source
- Class Antihypertensives
- Mechanism of Action ACE inhibitors; Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 07 Jun 2001 Profile reviewed but no significant changes made
- 16 Nov 1998 No-Development-Reported for Hypertension in France (PO)
- 06 Aug 1998 No-Development-Reported for Heart failure in France (Unknown route)